MDR & IVDR implementation – 7 MONTHS TO DATE OF APPLICATION 2 October 2019 Group 6Created with Sketch. 191002-Erik Vollebregt-MDR Countdown Group 6Created with Sketch. 191002-Paul van Geffen- Last elements before implementation Group 6Created with Sketch. 191002-Ronald Boumans- Latest on Eudamed Group 6Created with Sketch. 191002-Sue Spencer - IVDR Executive summary Read more
Compounding pharmacists – challenges for the (bio) pharmaceutical industry 17 April 2019 Group 6Created with Sketch. 190417-Hanneke-Later-Nijland Group 6Created with Sketch. 190417-slides andras kupecz-MK Group 6Created with Sketch. 190417-VIG PB Compounding Read more
Mainstreaming Personalised Health 6 March 2019 Group 6Created with Sketch. 190306-Mariette-Abrahams-QinaConsulting Group 6Created with Sketch. 190306-Kristofer-Cook-Carbiotix Group 6Created with Sketch. 190306-Karin-Verzijden-Axon-HDO Read more
MDR/IVDR Implementation: the transition period halfway point 10 October 2018 Group 6Created with Sketch. Anja-Wiersma-New performance evaluation data requirements and how to acquire those Group 6Created with Sketch. Erik-Vollebregt-Overview of issues, bottlenecks and opportunities halfway the transition period Group 6Created with Sketch. Gert Bos - How to work with your notified body for MDR transition Read more